Views on lipid-lowering medication and treatment decisions among statin intolerant patients and patients using statins who receive PCSK9 inhibitors

Ruben Mijnster; Janneke W. C. M. Mulder; Melvin Lafeber; Kubra Akgol; Marleen Kemper; Hugo Van Der Kuy; Inge Merkelbach; Jeanine Roeters Van Lennep

Views on lipid-lowering medication and treatment decisions among statin intolerant patients and patients using statins who receive PCSK9 inhibitors

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

Original language	English
Article number	120125
Number of pages	2
Journal	Atherosclerosis
Volume	407
Issue number	Supplement
Publication status	Published - Aug 2025
Event	93rd Congress of the European-Atherosclerosis-Society (EAS) - Glasgow Duration: 4 May 2025 → 7 May 2025

Access to Document

1-s2.0-S0021915025010238-mainFinal published version, 2.07 MBLicence: Article 25fa Dutch Copyright Act

https://doi.org/10.1016/j.atherosclerosis.2025.120125

Cite this

Mijnster, R., Mulder, J. W. C. M., Lafeber, M., Akgol, K., Kemper, M., Van Der Kuy, H., Merkelbach, I., & Van Lennep, J. R. (2025). Views on lipid-lowering medication and treatment decisions among statin intolerant patients and patients using statins who receive PCSK9 inhibitors. Atherosclerosis, 407(Supplement), Article 120125. https://doi.org/10.1016/j.atherosclerosis.2025.120125

@article{9bd08bd690b2466cabd9941dca7c5ecd,

title = "Views on lipid-lowering medication and treatment decisions among statin intolerant patients and patients using statins who receive PCSK9 inhibitors",

author = "Ruben Mijnster and Mulder, \{Janneke W. C. M.\} and Melvin Lafeber and Kubra Akgol and Marleen Kemper and \{Van Der Kuy\}, Hugo and Inge Merkelbach and \{Van Lennep\}, \{Jeanine Roeters\}",

year = "2025",

month = aug,

language = "English",

volume = "407",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

number = "Supplement",

note = "93rd Congress of the European-Atherosclerosis-Society (EAS) ; Conference date: 04-05-2025 Through 07-05-2025",

}

Mijnster, R, Mulder, JWCM , Lafeber, M, Akgol, K, Kemper, M, Van Der Kuy, H , Merkelbach, I & Van Lennep, JR 2025, 'Views on lipid-lowering medication and treatment decisions among statin intolerant patients and patients using statins who receive PCSK9 inhibitors', Atherosclerosis, vol. 407, no. Supplement, 120125. <https://doi.org/10.1016/j.atherosclerosis.2025.120125>

Views on lipid-lowering medication and treatment decisions among statin intolerant patients and patients using statins who receive PCSK9 inhibitors. / Mijnster, Ruben; Mulder, Janneke W. C. M.; Lafeber, Melvin et al.
In: Atherosclerosis, Vol. 407, No. Supplement, 120125, 08.2025.

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

TY - JOUR

T1 - Views on lipid-lowering medication and treatment decisions among statin intolerant patients and patients using statins who receive PCSK9 inhibitors

AU - Mijnster, Ruben

AU - Mulder, Janneke W. C. M.

AU - Lafeber, Melvin

AU - Akgol, Kubra

AU - Kemper, Marleen

AU - Van Der Kuy, Hugo

AU - Merkelbach, Inge

AU - Van Lennep, Jeanine Roeters

PY - 2025/8

Y1 - 2025/8

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:001540180500079&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 0021-9150

VL - 407

JO - Atherosclerosis

JF - Atherosclerosis

IS - Supplement

M1 - 120125

T2 - 93rd Congress of the European-Atherosclerosis-Society (EAS)

Y2 - 4 May 2025 through 7 May 2025

ER -

Views on lipid-lowering medication and treatment decisions among statin intolerant patients and patients using statins who receive PCSK9 inhibitors

Access to Document

Other files and links

Cite this